| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition.
|
Nat Med
|
2009
|
4.03
|
|
2
|
Virus-specific CD8+ T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation.
|
J Exp Med
|
2007
|
3.66
|
|
3
|
Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials.
|
Lancet
|
2012
|
2.54
|
|
4
|
Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival.
|
J Clin Oncol
|
2011
|
2.52
|
|
5
|
Immune surveillance by CD8αα+ skin-resident T cells in human herpes virus infection.
|
Nature
|
2013
|
2.38
|
|
6
|
Polymorphisms in TLR2 are associated with increased viral shedding and lesional rate in patients with genital herpes simplex virus Type 2 infection.
|
J Infect Dis
|
2007
|
2.33
|
|
7
|
Autoreactive T cells in healthy individuals.
|
J Immunol
|
2004
|
2.29
|
|
8
|
High incidence of ganciclovir-resistant cytomegalovirus infection among lung transplant recipients receiving preemptive therapy.
|
J Infect Dis
|
2001
|
1.85
|
|
9
|
A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition.
|
J Exp Med
|
2003
|
1.72
|
|
10
|
Protective HIV-specific CD8+ T cells evade Treg cell suppression.
|
Nat Med
|
2011
|
1.66
|
|
11
|
Repeat-region polymorphisms in the gene for the dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin-related molecule: effects on HIV-1 susceptibility.
|
J Infect Dis
|
2006
|
1.62
|
|
12
|
Vascular E-selectin expression correlates with CD8 lymphocyte infiltration and improved outcome in Merkel cell carcinoma.
|
J Invest Dermatol
|
2013
|
1.58
|
|
13
|
Herpes simplex virus infection of human dendritic cells induces apoptosis and allows cross-presentation via uninfected dendritic cells.
|
J Immunol
|
2005
|
1.53
|
|
14
|
Mucosal host immune response predicts the severity and duration of herpes simplex virus-2 genital tract shedding episodes.
|
Proc Natl Acad Sci U S A
|
2010
|
1.49
|
|
15
|
Diversity of the CD8+ T-cell response to herpes simplex virus type 2 proteins among persons with genital herpes.
|
J Virol
|
2006
|
1.43
|
|
16
|
Merkel cell polyomavirus-specific CD8⁺ and CD4⁺ T-cell responses identified in Merkel cell carcinomas and blood.
|
Clin Cancer Res
|
2011
|
1.36
|
|
17
|
T cell immunity to herpes simplex viruses in seronegative subjects: silent infection or acquired immunity?
|
J Immunol
|
2003
|
1.29
|
|
18
|
HSV-2: in pursuit of a vaccine.
|
J Clin Invest
|
2011
|
1.29
|
|
19
|
An extremely diverse CD4 response to vaccinia virus in humans is revealed by proteome-wide T-cell profiling.
|
J Virol
|
2008
|
1.27
|
|
20
|
Merkel polyomavirus-specific T cells fluctuate with merkel cell carcinoma burden and express therapeutically targetable PD-1 and Tim-3 exhaustion markers.
|
Clin Cancer Res
|
2013
|
1.22
|
|
21
|
Cross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine.
|
J Clin Invest
|
2012
|
1.16
|
|
22
|
Diversity in the acute CD8 T cell response to vaccinia virus in humans.
|
J Immunol
|
2005
|
1.16
|
|
23
|
Improved innate and adaptive immunostimulation by genetically modified HIV-1 protein expressing NYVAC vectors.
|
PLoS One
|
2011
|
1.16
|
|
24
|
Phase I study of a herpes simplex virus type 2 (HSV-2) DNA vaccine administered to healthy, HSV-2-seronegative adults by a needle-free injection system.
|
Clin Vaccine Immunol
|
2008
|
1.12
|
|
25
|
Fulminant, acyclovir-resistant, herpes simplex virus type 2 hepatitis in an immunocompetent woman.
|
J Clin Microbiol
|
2006
|
1.07
|
|
26
|
Uncovering the interplay between CD8, CD4 and antibody responses to complex pathogens.
|
Future Microbiol
|
2010
|
1.07
|
|
27
|
Evasion of the mucosal innate immune system by herpes simplex virus type 2.
|
J Virol
|
2009
|
1.05
|
|
28
|
Local CD4 and CD8 T-cell reactivity to HSV-1 antigens documents broad viral protein expression and immune competence in latently infected human trigeminal ganglia.
|
PLoS Pathog
|
2013
|
1.01
|
|
29
|
Diversity in CD8(+) T cell function and epitope breadth among persons with genital herpes.
|
J Clin Immunol
|
2010
|
1.01
|
|
30
|
Dominance and diversity in the primary human CD4 T cell response to replication-competent vaccinia virus.
|
J Immunol
|
2007
|
1.00
|
|
31
|
Expression of cutaneous lymphocyte-associated antigen and E-selectin ligand by circulating human memory CD4+ T lymphocytes specific for herpes simplex virus type 2.
|
J Infect Dis
|
2004
|
1.00
|
|
32
|
One-day regimen of valacyclovir for treatment of recurrent genital herpes simplex virus 2 infection.
|
Sex Transm Dis
|
2008
|
0.98
|
|
33
|
T-cell immunity to human alphaherpesviruses.
|
Curr Opin Virol
|
2013
|
0.98
|
|
34
|
Improved DNA vaccination by skin-targeted delivery using dry-coated densely-packed microprojection arrays.
|
J Control Release
|
2010
|
0.97
|
|
35
|
DNA vaccine delivery by densely-packed and short microprojection arrays to skin protects against vaginal HSV-2 challenge.
|
Vaccine
|
2010
|
0.96
|
|
36
|
Reduced levels of neutralizing antibodies to Kaposi sarcoma-associated herpesvirus in persons with a history of Kaposi sarcoma.
|
J Infect Dis
|
2004
|
0.96
|
|
37
|
Herpes simplex virus type 2 tegument proteins contain subdominant T-cell epitopes detectable in BALB/c mice after DNA immunization and infection.
|
J Gen Virol
|
2009
|
0.95
|
|
38
|
Virologic and immunologic evidence of multifocal genital herpes simplex virus 2 infection.
|
J Virol
|
2014
|
0.95
|
|
39
|
An effector phenotype of CD8+ T cells at the junction epithelium during clinical quiescence of herpes simplex virus 2 infection.
|
J Virol
|
2012
|
0.94
|
|
40
|
Safety and immunogenicity of long HSV-2 peptides complexed with rhHsc70 in HSV-2 seropositive persons.
|
Vaccine
|
2011
|
0.94
|
|
41
|
HHV-8 infection: a model for reactivation and transmission.
|
Rev Med Virol
|
2002
|
0.93
|
|
42
|
ORFeome approach to the clonal, HLA allele-specific CD4 T-cell response to a complex pathogen in humans.
|
J Immunol Methods
|
2009
|
0.91
|
|
43
|
Longitudinal analysis of herpes simplex virus-specific CD4+ cell clonotypes in infected tissues and blood.
|
J Infect Dis
|
2005
|
0.91
|
|
44
|
Vaxfectin-adjuvanted plasmid DNA vaccine improves protection and immunogenicity in a murine model of genital herpes infection.
|
J Gen Virol
|
2012
|
0.89
|
|
45
|
Use of acyclovir for suppression of human immunodeficiency virus infection is not associated with genotypic evidence of herpes simplex virus type 2 resistance to acyclovir: analysis of specimens from three phase III trials.
|
J Clin Microbiol
|
2010
|
0.88
|
|
46
|
CD4 T-cell memory responses to viral infections of humans show pronounced immunodominance independent of duration or viral persistence.
|
J Virol
|
2012
|
0.87
|
|
47
|
Public TCR use by herpes simplex virus-2-specific human CD8 CTLs.
|
J Immunol
|
2010
|
0.87
|
|
48
|
A novel DNA vaccine technology conveying protection against a lethal herpes simplex viral challenge in mice.
|
PLoS One
|
2013
|
0.86
|
|
49
|
Sequence-based methods for identifying epidemiologically linked herpes simplex virus type 2 strains.
|
J Clin Microbiol
|
2006
|
0.85
|
|
50
|
Cellular immunity in monozygotic twins discordant for chronic fatigue syndrome.
|
J Infect Dis
|
2002
|
0.84
|
|
51
|
Peripheral blood CD4 T-cell and plasmacytoid dendritic cell (pDC) reactivity to herpes simplex virus 2 and pDC number do not correlate with the clinical or virologic severity of recurrent genital herpes.
|
J Virol
|
2012
|
0.83
|
|
52
|
Immunobiology of herpes simplex virus and cytomegalovirus infections of the fetus and newborn.
|
Curr Immunol Rev
|
2010
|
0.83
|
|
53
|
Human CD4+ CD25 high cells suppress proliferative memory lymphocyte responses to herpes simplex virus type 2.
|
J Virol
|
2006
|
0.82
|
|
54
|
Recombinant Listeria monocytogenes expressing an immunodominant peptide fails to protect after intravaginal challenge with herpes simplex virus-2.
|
Arch Virol
|
2008
|
0.82
|
|
55
|
A case of Ramsay Hunt-like syndrome caused by herpes simplex virus type 2.
|
Clin Infect Dis
|
2005
|
0.80
|
|
56
|
Reduction of herpes simplex virus type-2 replication in cell cultures and in rodent models with peptide-conjugated morpholino oligomers.
|
Antivir Ther
|
2010
|
0.79
|
|
57
|
Serum and mucosal antibody responses to inactivated polio vaccine after sublingual immunization using a thermoresponsive gel delivery system.
|
Hum Vaccin Immunother
|
2014
|
0.78
|
|
58
|
Persistence of herpes simplex virus type 2 VP16-specific CD4+ T cells.
|
Hum Immunol
|
2005
|
0.77
|
|
59
|
The murine intravaginal HSV-2 challenge model for investigation of DNA vaccines.
|
Methods Mol Biol
|
2014
|
0.76
|
|
60
|
Doctor, why is my herpes so bad? The search continues.
|
J Infect Dis
|
2008
|
0.76
|
|
61
|
T-Cell Responses to HSV-1 in Persons Who Have Survived Childhood Herpes Simplex Encephalitis.
|
Pediatr Infect Dis J
|
2017
|
0.75
|